期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 65, 期 6, 页码 -出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00256-21
关键词
Talaromyces marneffei; olorofim
资金
- Intramural Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health
- Intramural Research Program of the National Institutes of Health, Clinical Center, Department of Laboratory Medicine
OLOROFIM exhibits the highest antifungal activity against both mold and yeast phases of Talaromyces marneffei isolates.
In vitro antifungal susceptibility profiling of 32 clinical and environmental Talaromyces marneffei isolates recovered from southern China was performed against olorofim and 7 other systemic antifungals, including amphotericin B, 5-flucytosine, posaconazole, voriconazole, caspofungin, and terbinafine, using CLSI methodology. In comparison, olorofim was the most active antifungal agent against both mold and yeast phases of all tested Talaromyces marneffei isolates, exhibiting an MIC range, MIC50, and MIC90 of 0.0005 to 0.002 mu g/ml, 0.0005 mu g/ml, and 0.0005 mu g/ml, respectively.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据